drugset / Press release
Exciting new CS6253 data will be presented at AD/PD 2019 meeting in Lisbon, Portugal.
2019-03-27 · Artery Therapeutics, Inc. · original arterytx.com ↗
Exciting new CS6253 data will be presented at AD/PD 2019 meeting in Lisbon, Portugal. Oral presentation by Dr. Jan Johansson Title: Prevention of ABCA1 aggregation and degradation by CS6253 to address apoE4 associated neurodegeneration and Alzheimer's disease Session: Symposium 03: ApoE mechanisms and treatment strategies Room: Auditorium VIII Date: March 27th Time: 10 AM - 10.15 AM
The release as fetched from its publisher. arterytx.com ↗